HIV-1 rebound after anti-retroviral therapy

被引：43

作者：

Ho, DD ^{[1
]}

Zhang, LQ ^{[1
]}

机构：

[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA

来源：

NATURE MEDICINE | 2000年 / 6卷 / 07期

关键词：

D O I：

10.1038/77447

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

In patients with human immunodeficiency virus 1, a comparison of the genotype of rebounding virus to that In the latent reservoir after highly active anti-retroviral therapy is discontinued indicates that the latent reservoir is not the cause of viral rebound in most cases. However, the precise anatomic location of the source of viral rebound is still undefined (pages 757-761).

引用

页码：736 / 737

页数：2

共 50 条

[1] HIV-1 rebound after anti-retroviral therapy
David D. Ho
Linqi Zhang
[J]. Nature Medicine, 2000, 6 : 736 - 737
[2] A possible origin of emerged HIV-1 after interrupting anti-retroviral therapy
Matsumura, Jiro
Shimizu, Masumi
Omi, Kyoko
Nagata, Naoyoshi
Shinya, Eiji
Oka, Shinichi
Takahashi, Hidemi
[J]. BIOMEDICAL RESEARCH-TOKYO, 2014, 35 (01): : 1 - 8
[3] Numerical modelling of the perturbation of HIV-1 during combination anti-retroviral therapy
Gumel, AB
Loewen, TD
Shivakumar, PN
Sahai, BM
Yu, P
Garba, ML
[J]. COMPUTERS IN BIOLOGY AND MEDICINE, 2001, 31 (05) : 287 - 301
[4] Development of anti-retroviral resistance of HIV-1 infected individuals on therapy: Is it inevitable?
Kolber, MA
Campo, RE
Dickinson, GM
[J]. IUBMB LIFE, 2004, 56 (06) : 301 - 307
[5] HIV-1 group O sensitivity to anti-retroviral drugs
Descamps, D
Collin, G
LoussertAjaka, I
Bouchaud, O
Simon, F
Sarragosti, S
BrunVezinet, F
[J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 18 - 18
[6] Resistance to anti-retroviral therapy in Chilean patients with HIV-1 from 2002 to 2005
Afani, Alejandro S.
Orellana, Laura R.
Duarte, Paula J.
Acevedo, Wiliam M.
Morales, Omar B.
Wolff, Marcelo R.
Vasquez, Patricia
Beltran, Carlos
[J]. REVISTA MEDICA DE CHILE, 2007, 135 (10) : 1237 - 1244
[7] Autoantibodies Among HIV-1 Infected Individuals and the Effect of Anti-Retroviral Therapy (ART) on It
Steve, Runal John
Alex, Diviya
Yesudhason, Binesh Lal
Prakash, John Antony Jude
Mathews, Nitty Skari-ah
Daniel, Dolly
Ramalingam, Veena Vadhini
Demosthenes, John Paul
Ghale, Ben Chirag
Anantharam, Raghavendran
Rebekah, Grace
Rupali, Priscilla
Varghese, George Mannil
Kannangai, Rajesh
[J]. CURRENT HIV RESEARCH, 2021, 19 (03) : 277 - 285
[8] The effectiveness of anti-retroviral drug therapy for HIV-1 is associated with HIV-1 proviral DNA levels and viral selection
Ariyama, I
Chong, Y
Murata, M
Nabeshima, S
Ikematsu, H
Kashiwagi, S
Hayashi, J
[J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2002, 30 (03) : 289 - 300
[9] Can interruption/withdrawl of anti-retroviral therapy provide personalized immunotherapy against HIV-1?
Bretscher, Peter A.
Al-Yassin, Ghassan
[J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 92 (06)
[10] Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
Mark E. Sharkey
Ian Teo
Thomas Greenough
Natalia Sharova
Katherine Luzuriaga
John L. Sullivan
R. Pat Bucy
Leondios G. Kostrikis
Ashley Haase
Claire Veryard
Raul E. Davaro
Sarah H. Cheeseman
Jennifer S. Daly
Carol Bova
Richard T. Ellison
Brian Mady
Kwan Kew Lai
Graeme Moyle
Mark Nelson
Brian Gazzard
Sunil Shaunak
Mario Stevenson
[J]. Nature Medicine, 2000, 6 : 76 - 81

← 1 2 3 4 5 →